This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Kinki University. Active years: 2018-2024.
Location History:
- Kinokawa, JP (2018)
- Wakayama, JP (2024)
Company Filing History:
Years Active: 2018-2024
Title: Saori Kunii: Innovator in Therapeutic Agents for Intervertebral Disc Degeneration
Introduction
Saori Kunii is a prominent inventor based in Kinokawa, Japan. She has made significant contributions to the field of therapeutic agents, particularly focusing on intervertebral disc degeneration. With a total of 2 patents, her work is paving the way for advancements in medical treatments.
Latest Patents
Saori Kunii's latest patents include innovative solutions for intervertebral disc degeneration. The first patent is a therapeutic agent that contains LASCol, which is obtained by enzymatically cleaving a terminus of collagen. This agent aims to address the challenges associated with intervertebral disc degeneration. The second patent focuses on a composition for inducing differentiation, which describes the use of a degradation product containing at least a portion of the triple helical domain of collagen or atelocollagen. This composition and method are designed to enhance the production of differentiation-inducing substances.
Career Highlights
Saori Kunii is affiliated with Kinki University, where she continues her research and development in the field of therapeutic agents. Her work is characterized by a commitment to improving medical treatments and enhancing patient outcomes.
Collaborations
Saori collaborates with notable colleagues, including Koichi Morimoto and Ei Yamamoto. Their combined expertise contributes to the innovative research being conducted at Kinki University.
Conclusion
Saori Kunii is a trailblazer in the development of therapeutic agents for intervertebral disc degeneration. Her patents reflect her dedication to advancing medical science and improving the quality of life for patients.